Tokyo, July 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058594) titled 'A systematic review of the functionality of "GABA" for lowering blood pressure, update version' on July 25.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - The subjects are people with normal blood pressure and people with higher blood pressure (including people with high-normal blood pressure and stage 1 hypertension). *Those who are not excluding those under 18 years old, pregnant women, and lactating women. Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate include the latest clinical research reports whether the intake of GABA improves systolic blood pressure and diastolic blood pressure in people with normal blood pressure and people with higher blood pressure (including people with high-normal blood pressure and stage 1 hypertension). Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - P-Participant: Participant The subjects are people with normal blood pressure and people with higher blood pressure (including people with high-normal blood pressure and stage 1 hypertension). *Those who are not excluding those under 18 years old, pregnant women, and lactating women.

I-intervention: Intervention (food) characteristics Continuous intake of GABA, Unlimited dosage forms, period and follow-up period.

C-Comparison: Comparison Placebo (The placebo's formulation is not specified)

O-Outcome: Outcome The primary outcome: systolic blood pressure and diastolic blood pressure

S-Study design: Study design Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials, open trials. Key exclusion criteria - The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 06 Month 30 Day Anticipated trial start date - 2025 Year 07 Month 25 Day Last follow-up date - 2025 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066992

Disclaimer: Curated by HT Syndication.